BRIEF-Valeant gets lender consent for credit facility amendment
April 7 (Reuters) - Valeant Pharmaceuticals International Inc
* Valeant Pharmaceuticals receives lender consent for credit facility amendment
* Company expects to close amendment and waiver next week.
* Remains well positioned to meet its obligations Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.